|Videos|March 12, 2021
Recent Advances in the Treatment of Hereditary ATTR Amyloidosis (hATTR)
Author(s)John L. Berk, MD
P. James B. Dyck, MD
P. James B. Dyck, MD
Key insight into treating ATTR Amyloidosis, including the use of new therapeutic options to provide a practical perspective on how recent data may apply to your clinical practice.
Advertisement
Newsletter
Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.
Advertisement
Related Articles
- Clinical Pearls for CIDP Management
May 29th 2025
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive
1
Stem Cells of Secondary Progressive Multiple Sclerosis Drive Increased Proinflammatory T-Cell Activity
2
EMA Approves Semaglutide as First GLP-1 RA for Cardiovascular, Stroke-Related Benefits
3
Del-Zota Reverses Duchenne Disease Progression in 1-Year Trial Update
4
Postmortem Analysis Reveals Distinct Patterns of Aquaporin-4 in Parkinson Disease and Multiple System Atrophy
5